Drug: efalizumab. Reduction in number of inflammatory lesions 12 weeks post-baseline|Time to the reduction of lesions during 12 weeks...
Archive for category: Clinical Trials
, Clinical Trials, Research, Treatment, 0
Biological: CJM112. Clinical responder rate|Safety and tolerability as measured by frequency of adverse events|Pharmacokinetic profile|Immunogenicity|Safety and tolerability as measured...
The goal of this study is to find out what causes hidradenitis suppurativa. Hidradenitis suppurativa is a chronic skin...
, Clinical Trials, Acne Inversa, Dermatology, Treatment, 0
AbbVie announced that the European Commission has approved Humira for treating moderate-to-severe hidradenitis suppurativa in adults with inadequate response...
HS Patient Stories
HS BOOK SERIES: “I WILL NOT HIDE” Hidradenitis suppurativa (HS)
Our series of book releases for #HSAWARENESS tell the stories of Hidradenitis Suppurativa (HS) patients in vivid and personal narrative. Told by the patients themselves.
“New updates on HS underscores the role of various genes as well as the innate and adaptive immune response in its pathogenesis.”
— Barlev D, Eisen DB, Alikhan A